Compare Petrosea Tbk. (PTRO) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Petrosea Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Petrosea Tbk. trades at Rp5,400 (market cap 54.97T, 34.43M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Petrosea Tbk. is far larger — about 526.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PTRO | SCPI | |
|---|---|---|
Market Cap | 54.97T | 104.4B |
Volume | 34.43M | — |
Lot | 344.3K | — |
Turnover | 185B | — |
Average Price | 5,373.22 | — |
Value | 185B | — |
Indicative Equilibrium Price | 5,400 | — |
Indicative Equilibrium Volume | 12.22K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Petrosea Tbk.
PT Petrosea Tbk (yhe Company) was established under Notarial Deed No.75, dated February 21, 1972, of Djojo Muljadi, LLM, Public Notary in Jakarta, within the framework of the Foreign Capital Investment Law of 1967. PT Petrosea operates in engineering construction and contract mining services. The major shares were taken over by Clough Engineering Group of Australia in 1984.
Read more on PTRO →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
